Chromium next GEM single cell multiome atac + gene expression reagent bundle 4 rxns, chromium nuclei isolation with rnase inhibitor kit 16RXNS, chromium next GEM single cell 3' kit V3.1 4 rxns,…
Ended Awarded
- Contract number
- 75N95024F00004
- Awardee
-
10X Genomics, Inc. UEI D1NLDEZ14TV5
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $107,098
Award facts
- Contract value 100% obligated
- $107,098.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Pleasanton, CA 94588, USA
Award details come from SAM.gov/FPDS.
About this award
This firm fixed price delivery order, valued at $107,098.30, was awarded to 10X Genomics, Inc. by the National Institute of Neurological Disorders and Stroke (NINDS), a component of the U.S. Department of Health and Human Services' National Institutes of Health (NIH). The contract provides various 10X Genomics products and services to support NINDS research efforts, including Chromium Next GEM single cell multiome ATAC + gene expression reagent bundles, Chromium nuclei isolation kits, Chromium Next GEM single cell 3' kits, and Chromium Next GEM chips. This delivery order is part of a larger $750,000 indefinite delivery contract with NINDS for optimization slides, reagents kits, and reagent delivery methods. The contract does not utilize a set-aside designation. The award date is September 3, 2024, with a completion date of September 17, 2024.
Description
Chromium next GEM single cell multiome atac + gene expression reagent bundle 4 rxns, chromium nuclei isolation with rnase inhibitor kit 16RXNS, chromium next GEM single cell 3' kit V3.1 4 rxns, chromium next GEM chip g single cell kit 16 rxns, d
Quick answers
Who was awarded contract 75N95024F00004?
75N95024F00004 was awarded to 10X Genomics, Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 3, 2024.
How much is contract 75N95024F00004 worth?
The government has obligated $107,098 on 75N95024F00004.
Which agency awarded contract 75N95024F00004?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95024F00004, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Is contract 75N95024F00004 an order under another contract?
Yes. 75N95024F00004 is a delivery order under 75N95023D00018, an indefinite delivery contract.
Was contract 75N95024F00004 competed?
The extent of competition for 75N95024F00004 was not competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award